Abbott Laboratories (NYSE:ABT) ranks among the top picks for a retirement portfolio. UBS maintained Abbott Laboratories (NYSE ...
Abbott Laboratories (NYSE:ABT) reported a 6.9% increase in sales for the second quarter of 2025. The earnings report, ...
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.
Boudreau guided for Q3 adjusted EPS of $1.28 to $1.32. Management reaffirmed full-year expectations of high single-digit growth and double-digit EPS growth, despite headwinds from diagnostics and ...
The North American precision nutrition market offers significant growth opportunities driven by U.S. dominance, burgeoning ...
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Suburban-based Abbott Laboratories says it will spend $500 million on two manufacturing facilities, including one in ...
Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4 ...
Abbott reported Q4 sales of $11 billion missing the consensus; adjusted EPS was $1.34, matching analyst estimates Medical Device sales surged 13.7% to $5.05 billion, with FreeStyle Libre and AVEIR ...
New Zealand dairy and infant-formula business Synlait Milk has agreed to sell its North Island assets to the local unit of US ...
A St. Louis judge has granted a new trial in a case Abbott Laboratories won in the fall, in which a mother alleged that the company’s cow’s milk-based products for premature infants contributed to her ...
Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the trades showed up on publicly ...
Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...